Your browser doesn't support javascript.
loading
Role of Interferon (IFN)α in "Cocktails" for the Generation of (Leukemia-derived) Dendritic Cells (DCleu) From Blasts in Blood From Patients (pts) With Acute Myeloid Leukemia (AML) and the Induction of Antileukemic Reactions.
Hirn Lopez, Annika; Deen, Diana; Fischer, Zuzanna; Rabe, Alexander; Ansprenger, Christian; Stein, Kathy; Vogt, Valentin; Schick, Julia; Kroell, Tanja; Kraemer, Doris; Kolb, Hans-Jochem; Tischer, Johanna; Schmid, Christoph; Schmetzer, Helga.
Afiliação
  • Hirn Lopez A; Department for Hematopoetic Cell Transplantation, Med. Dept.3, Workgroup Immunomodulation, University Hospital of Munich, Munich.
  • Deen D; Department for Hematopoetic Cell Transplantation, Med. Dept.3, Workgroup Immunomodulation, University Hospital of Munich, Munich.
  • Fischer Z; Department for Hematopoetic Cell Transplantation, Med. Dept.3, Workgroup Immunomodulation, University Hospital of Munich, Munich.
  • Rabe A; Department for Hematopoetic Cell Transplantation, Med. Dept.3, Workgroup Immunomodulation, University Hospital of Munich, Munich.
  • Ansprenger C; Department for Hematopoetic Cell Transplantation, Med. Dept.3, Workgroup Immunomodulation, University Hospital of Munich, Munich.
  • Stein K; Department for Hematopoetic Cell Transplantation, Med. Dept.3, Workgroup Immunomodulation, University Hospital of Munich, Munich.
  • Vogt V; Department for Hematopoetic Cell Transplantation, Med. Dept.3, Workgroup Immunomodulation, University Hospital of Munich, Munich.
  • Schick J; Department for Hematopoetic Cell Transplantation, Med. Dept.3, Workgroup Immunomodulation, University Hospital of Munich, Munich.
  • Kroell T; Department for Hematopoetic Cell Transplantation, Med. Dept.3, Workgroup Immunomodulation, University Hospital of Munich, Munich.
  • Kraemer D; Department for Hematology and Oncology, Municipal Hospital, Oldenburg.
  • Kolb HJ; Department for Hematopoetic Cell Transplantation, Med. Dept.3, Workgroup Immunomodulation, University Hospital of Munich, Munich.
  • Tischer J; Department for Hematopoetic Cell Transplantation, Med. Dept.3, Workgroup Immunomodulation, University Hospital of Munich, Munich.
  • Schmid C; Department for Hematopoetic Cell Transplantation, Municipal Hospital Augsburg, University Hospital Augsburg, Germany.
  • Schmetzer H; Department for Hematopoetic Cell Transplantation, Med. Dept.3, Workgroup Immunomodulation, University Hospital of Munich, Munich.
J Immunother ; 42(5): 143-161, 2019 06.
Article em En | MEDLINE | ID: mdl-31090655
ABSTRACT
Strategies to stabilize remissions by specific elimination of residual acute myeloid leukemia (AML) blasts are needed. Leukemia-derived dendritic cell (DCleu/DC) generated from myeloid blasts improve antileukemic T-cell reactivity and install T-cell memory. Interferon (IFN)α-DC methods produce DCleu from chronic myeloid leukemia-patients (pts') blood. Various INFα-containing versus other DC methods were studied to produce DCleu (evaluated by flowcytometry) from AML-pts' blast-containing mononuclear (MNC) or whole blood (WB). After DCleu/DC stimulation in mixed lymphocyte cultures, T cells' potential to gain antileukemic cytotoxicity was studied and correlated with different DC methods and DCleu/DC counts. (1) Generation of DCleu/DC (a) "IFN-GIT" [containing granulocyte macrophage-colony stimulating factor (GM-CSF)+IFNα+ tumor necrosis factor (TNF)-α] produced DC successfully (≥10% DC, ≥5% DCleu/cells) from AML-MNC (WB) in 54 (56%), "MCM-Mimic" in 76 (75%), "Picibanil" in 83 (64%), and "Calcium-ionophore" in 42 (67%) of cases. Proportions of DC subtypes in MNC (WB) were comparable with all DC methods, (b) IFNα combinations containing only GM-CSF+IFNα or only IFNα showed low efficiency to produce DCleu/DC from MNC (WB) compared with "IFN-GIT." (2) Antileukemic functionality DCleu/DC-stimulated T cells showed improved leukemia cytotoxicity compared with blast cells or unstimulated T cells. The highest blast proliferation (=insufficient T cells) was seen with "IFN-GIT" DC-stimulated T cells. Probability to respond to immunotherapy or to obtain blast lysis of DC-stimulated T cells correlated with high proportions of DCleu/DC after DC culture, independent of DC-generating methods. (3) Cytokine release profiles levels of interleukin-6, IFN-γ, and interleukin-2 were significantly lower in DC culture supernatants (from MNC/WB) with "IFN-GIT" compared with "MCM," "Pici," and "Ca" DC supernatants. Our data show that (1) WB culture simulates AML-pts' in vivo situation, (2) DC generation is possible from AML-MNC (WB) with IFNα-containing and other DC methods, (3) successful IFNα-DC generation needs GM-CSF+IFNα+TNF-α (IFN-GIT); however, "IFN-GIT" produces less DCleu/DC compared with other (non-IFNα) DC methods, (4) T cells stimulated with "IFN-GIT"-produced DCleu/DC yielded comparable antileukemic cytotoxicity; however, in cases without achieved blast lysis, an increased blast proliferation was observed.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Dendríticas / Leucemia Mieloide Aguda / Citocinas / Interferon-alfa / Imunoterapia Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Dendríticas / Leucemia Mieloide Aguda / Citocinas / Interferon-alfa / Imunoterapia Idioma: En Ano de publicação: 2019 Tipo de documento: Article